Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ADM Korea is a leading South Korean Contract Research Organization (CRO) that provides a full suite of clinical trial management services to the pharmaceutical, biotech, and medical device industries. Founded in 2003, the company offers end-to-end solutions including clinical trial design, regulatory consulting, data management, and biostatistics for Phase 1 through Phase 4 studies. ADM Korea is particularly noted for its strong presence in the Asia-Pacific region and its expertise in complex therapeutic areas such as oncology and metabolic diseases. The company is listed on the KOSDAQ exchange and was acquired by Mobiis in 2024 to strengthen its position in the global healthcare services market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ADM Korea.